glutamic acid has been researched along with Cerebrovascular Disorders in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (8.89) | 18.7374 |
1990's | 28 (62.22) | 18.2507 |
2000's | 5 (11.11) | 29.6817 |
2010's | 8 (17.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, B; Kim, E; Lee, D; Lee, YB; Moon, C; Son, G; Soo Han, H; Yoo, SJ | 1 |
Cintado-Benítez, A; Cruz-Ramírez, A; Delgado-Roche, L; Fernández-Massó, JR; Llópiz-Arzuaga, A; Marín-Prida, J; Mendoza-Marí, Y; Nazábal-Gálvez, M; Pardo-Andreu, GL; Pavón-Fuentes, N; Pentón-Arias, E; Pentón-Rol, G; Polentarutti, N; Riva, F; Santana, SP; Valenzuela-Silva, C | 1 |
Berestovitskaia, VM; Kurkin, DV; Mazina, NV; Vasil'eva, OS; Volotova, EV | 1 |
Fan, Y; Gao, Y; Liu, X; Sun, D; Wu, G; Yan, Y; Zeng, J; Zhang, J | 1 |
Fedinec, AL; Leffler, CW; Liu, J; Parfenova, H | 1 |
Funke-Kaiser, H; Godes, M; Hörtnagl, H; Krikov, M; Lucht, K; Müller, S; Namsolleck, P; Neumann, C; Rumschüssel, K; Schefe, JH; Schmerbach, K; Steckelings, UM; Thöne-Reineke, C; Unger, T; Villringer, A | 1 |
Egea-Guerrero, JJ; Muñoz-Sánchez, MA; Murillo-Cabezas, F; Revuelto-Rey, J | 1 |
Jin, GR; Wang, JH; Zhang, HJ; Zhao, LD; Zhao, Y | 1 |
Gonzales, MM; Haley, AP; Tanaka, H; Tarumi, T | 1 |
Lorenzo Fernández, P | 1 |
Berger, C; Schramm, P; Schwab, S | 1 |
Ashimine, S; Fukuda, T; Miyazato, M; Nishijima, S; Ogawa, Y; Sugaya, K | 1 |
Chen, YC; Huang, CI; Lee, CH; Lin, MT; Liu, YC; Wang, LM; Yen, DH | 1 |
Cohen, G; Weinberger, J | 1 |
Bullock, R; Woodward, J; Young, HF; Zauner, A | 1 |
Chan, PH; Hirose, K | 1 |
Chai, CY; Yang, TL; Yen, CT | 1 |
Castillo, J; Dávalos, A; Naveiro, J; Noya, M | 1 |
Addae, JI; Evans, SM | 1 |
Castillo, J; Dávalos, A; Noya, M | 1 |
Leutwyler, K | 1 |
Castillo, J; Dávalos, A; Noya, M; Serena, J | 1 |
McCulloch, J | 1 |
Ho, DY; Sapolsky, RM | 1 |
Fischer, KM | 1 |
Giusti, P; Manev, H; Uz, T | 1 |
Blomstrand, F; Hansson, E; Khatibi, S; Olsson, T; Rönnbäck, L | 1 |
Kempski, OS; Lowitzsch, K; Stover, JF | 1 |
Bredt, DS | 1 |
Cai, H; Colagiuri, S; Wang, X; Wilcken, DE | 1 |
Kobayashi, T; Mori, Y | 1 |
Berg-Johnsen, J; Haugstad, TS; Langmoen, IA | 1 |
de Groat, WC; Namiki, M; Yokoyama, O; Yoshiyama, M | 1 |
Goodall, S; Ofer, E; Reggia, JA; Revett, K; Ruppin, E | 1 |
Cumming, A; Dahiyat, MT; MacLeod, MJ; Meiklejohn, D; Shaw, D; St Clair, D | 1 |
Hardy, J | 1 |
Dudkowska-Konopa, A; Gieracz-Nazar, A; Kawiak, W; Nowicki, J | 1 |
Choi, DW; Zivin, JA | 1 |
Grunfeld, S; Joseph, R; Tsering, C; Welch, KM | 1 |
Naik, B; Silverstein, FS; Simpson, J | 1 |
Mazzarella, V; Zivin, JA | 1 |
Marangos, PJ | 1 |
Barnes, DM | 1 |
Baethmann, A; Guggenbichler, C; Jacob, K; Kempski, O; Lange, M; Maier-Hauff, K; Schürer, L; Vogt, W | 1 |
Becker, DP; Cheung, M; Povlishock, J; Verity, MA | 1 |
9 review(s) available for glutamic acid and Cerebrovascular Disorders
Article | Year |
---|---|
[Cerebral microdialysis in the current clinical setting].
Topics: Animals; Brain Chemistry; Brain Damage, Chronic; Brain Injuries; Cerebrovascular Disorders; Critical Care; Energy Metabolism; Glucose; Glutamic Acid; Glycerol; Humans; Hypoxia, Brain; Lactates; Microdialysis; Monitoring, Physiologic; Prognosis; Pyruvates | 2012 |
Blockade of glutamate excitotoxicity and its clinical applications.
Topics: Animals; Brain Ischemia; Cell Death; Cerebrovascular Disorders; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Ion Channels; Neurons | 1993 |
The role of glutamic acid in the pathogenesis of stroke and the development of neuroprotective drugs.
Topics: Brain Damage, Chronic; Cerebrovascular Disorders; Glutamic Acid; Humans; Neuroprotective Agents; Receptors, Glutamate | 1995 |
Neuroprotective drug development in stroke: blood pressure and its impact.
Topics: Animals; Blood Pressure; Brain Damage, Chronic; Brain Ischemia; Cerebrovascular Disorders; Disease Models, Animal; Glutamic Acid; Humans; Neuroprotective Agents | 1996 |
Neuroprotective action of the pineal hormone melatonin against excitotoxicity. Receptor abuse-dependent antagonism (RADA).
Topics: Animals; Cerebrovascular Disorders; Glutamic Acid; Humans; Kainic Acid; Melatonin; Neuroprotective Agents; Neurotoxins; Pineal Gland; Rats; Receptors, Glutamate | 1997 |
Ca2+ channel antagonists and neuroprotection from cerebral ischemia.
Topics: Animals; Apoptosis; Brain Ischemia; Calcium Channel Blockers; Calcium Channels; Cerebrovascular Disorders; Glutamic Acid; Humans; Neuroprotective Agents | 1998 |
Glutamate in the human brain: possible roles in synaptic transmission and ischemia.
Topics: Brain; Brain Ischemia; Cerebrovascular Disorders; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Synaptic Transmission | 1998 |
Platelet secretory products may contribute to neuronal injury.
Topics: Animals; Blood Platelets; Brain Ischemia; Cerebrovascular Disorders; Gliosis; Glutamates; Glutamic Acid; Humans; Nervous System Diseases; Neurons; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Serotonin | 1991 |
Brain cellular injury and recovery--horizons for improving medical therapies in stroke and trauma.
Topics: Adult; Animals; Axons; Brain Concussion; Brain Injuries; Cats; Cerebrovascular Disorders; Glutamates; Glutamic Acid; Humans; Male | 1988 |
2 trial(s) available for glutamic acid and Cerebrovascular Disorders
Article | Year |
---|---|
The influence of glucose load on gamma-glutamyl-transpeptidase (GGTP) activity in the serum of patients with acute disturbances of the cerebral circulation.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cerebrovascular Disorders; Female; gamma-Glutamyltransferase; Glucose Tolerance Test; Glutamic Acid; Humans; Liver Function Tests; Male; Middle Aged | 1992 |
Stroke therapy.
Topics: Animals; Arterial Occlusive Diseases; Calcium; Cell Survival; Cerebral Arterial Diseases; Cerebrovascular Disorders; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Humans; Intracranial Embolism and Thrombosis; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Tissue Plasminogen Activator; Tomography, Emission-Computed | 1991 |
34 other study(ies) available for glutamic acid and Cerebrovascular Disorders
Article | Year |
---|---|
The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Caspase 3; Cell Death; Cerebral Cortex; Cerebrovascular Disorders; Embryo, Mammalian; Erythropoietin; Gene Expression Regulation; Glutamic Acid; Janus Kinase 2; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Middle Cerebral Artery; Mitochondria; Neurons; Neuroprotective Agents; Peptides; Permeability; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Stroke | 2017 |
Phycocyanobilin promotes PC12 cell survival and modulates immune and inflammatory genes and oxidative stress markers in acute cerebral hypoperfusion in rats.
Topics: Animals; Biomarkers; Brain Chemistry; Cell Survival; Cerebrovascular Disorders; Coloring Agents; Cytokines; Genes, MHC Class II; Glutamic Acid; Hydrogen Peroxide; Inflammation; Male; Microarray Analysis; Oxidation-Reduction; Oxidative Stress; PC12 Cells; Phycobilins; Phycocyanin; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Spirulina; Tetrazolium Salts; Thiazoles; Vascular Endothelial Growth Factor A | 2013 |
[Comparative analysis of action of beta-phenyl derivatives of glutamic and gamma-aminobutyric acid on cerebral blood flow and cerebrovascular endothelium after irreversible occlusion of the common carotid artery].
Topics: Animals; Blood Flow Velocity; Brain; Carotid Artery, Common; Cerebrovascular Disorders; Endothelium, Vascular; gamma-Aminobutyric Acid; Glutamic Acid; Male; Protective Agents; Rats; Survival Analysis; Vasodilation; Vasodilator Agents | 2013 |
Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors.
Topics: Aged; Biomarkers; Cerebrovascular Disorders; Cognition; Cognition Disorders; Cross-Sectional Studies; Executive Function; Female; Glutamic Acid; Glutamine; Hippocampus; Humans; Male; Memory, Short-Term; Mental Recall; Middle Aged; Neuropsychological Tests; Predictive Value of Tests; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Risk Factors | 2014 |
Enteral supplements of a carbon monoxide donor CORM-A1 protect against cerebrovascular dysfunction caused by neonatal seizures.
Topics: Adenosine Diphosphate; Animals; Arterioles; Boranes; Bradykinin; Carbon Monoxide; Carbonates; Cerebrovascular Circulation; Cerebrovascular Disorders; Dietary Supplements; Excitatory Amino Acid Agonists; Female; Glutamic Acid; Heme; Male; Quisqualic Acid; Seizures; Swine; Time Factors; Vasodilator Agents | 2015 |
The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke.
Topics: Animals; Anti-Bacterial Agents; Body Temperature; Brain; Brain Infarction; Ceftriaxone; Cerebrovascular Disorders; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Interleukin-6; Male; Nerve Growth Factors; Rats; Rats, Wistar; Regional Blood Flow; RNA, Messenger; Stroke; Survival Rate | 2008 |
Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats--time window and mechanism.
Topics: Animals; Cerebral Infarction; Cerebrovascular Disorders; Drugs, Chinese Herbal; Glutamic Acid; Ischemic Attack, Transient; Magnoliopsida; Male; Nervous System Diseases; Neuroprotective Agents; Oligochaeta; Phytotherapy; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reperfusion Injury; RNA, Messenger; Stroke; Time Factors | 2012 |
Subclinical vascular disease and cerebral glutamate elevation in metabolic syndrome.
Topics: Adult; Brain Chemistry; Carotid Intima-Media Thickness; Cerebrovascular Disorders; Data Interpretation, Statistical; Female; Glutamic Acid; Health Status; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Metabolic Syndrome; Middle Aged; Neuropsychological Tests; Risk Factors; Socioeconomic Factors | 2012 |
[Neuroprotection by aspirin in cerebrovascular pathology].
Topics: Adenosine Triphosphate; Algorithms; Amino Acid Transport System X-AG; Animals; Aspirin; Brain Ischemia; Cell Death; Cerebrovascular Disorders; Clinical Trials as Topic; Disease Models, Animal; Glucose; Glutamic Acid; Humans; Indomethacin; Mitochondria; Neuroprotective Agents; Oxygen; Salicylates | 2002 |
Reduction of diffusion-weighted MRI lesion volume after early moderate hypothermia in ischemic stroke.
Topics: Brain; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Diffusion; Diffusion Magnetic Resonance Imaging; Glutamic Acid; Humans; Hypothermia; Hypothermia, Induced; Magnetic Resonance Imaging; Male; Middle Aged; Middle Cerebral Artery; Reperfusion; Stroke; Thrombolytic Therapy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Cerebrovascular Disorders; Electrophoresis, Capillary; Female; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Prognosis; Severity of Illness Index; Sex Factors; Spinal Nerves; Urination Disorders; Urodynamics | 2006 |
L-arginine causes amelioration of cerebrovascular dysfunction and brain inflammation during experimental heatstroke.
Topics: Animals; Arginine; Cerebrovascular Circulation; Cerebrovascular Disorders; Cytokines; Encephalitis; Enzyme-Linked Immunosorbent Assay; Glutamic Acid; Glycerol; Heat Stroke; Hypothalamus; Interleukin-10; Interleukin-1beta; Intracranial Hypertension; Intracranial Pressure; Lactic Acid; Nitric Oxide; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2008 |
The differential effect of ischemia on the active uptake of dopamine, gamma-aminobutyric acid, and glutamate by brain synaptosomes.
Topics: Animals; Brain; Brain Ischemia; Carotid Arteries; Cerebrovascular Disorders; Dopamine; gamma-Aminobutyric Acid; Gerbillinae; Glutamates; Glutamic Acid; Synaptosomes | 1982 |
Massive persistent release of excitatory amino acids following human occlusive stroke.
Topics: Aspartic Acid; Carotid Artery, Internal; Carotid Stenosis; Cerebrovascular Disorders; Excitatory Amino Acids; Glutamic Acid; Humans; Male; Middle Aged | 1995 |
Enhanced sympathetic reactivity to glutamate stimulation in medulla oblongata of spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Brain Mapping; Cerebrovascular Disorders; Electric Stimulation; Glutamic Acid; Hypertension; Kidney; Male; Medulla Oblongata; Neurons; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rest; Sympathetic Nervous System; Vasomotor System | 1995 |
Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Aspartic Acid; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Excitatory Amino Acids; Female; Glutamic Acid; Glycine; Humans; Logistic Models; Male; Middle Aged; Neurologic Examination; Severity of Illness Index; Taurine; Tomography, X-Ray Computed | 1996 |
Progression of ischaemic stroke and excitotoxic aminoacids.
Topics: Aged; Cerebral Infarction; Cerebrovascular Disorders; Excitatory Amino Acids; Glutamic Acid; Glycine; Humans; Logistic Models; Middle Aged; Prospective Studies; Severity of Illness Index | 1997 |
Stopping strokes. Drugs in development may protect the brain from harm.
Topics: Animals; Apoptosis; Cerebrovascular Disorders; Glutamic Acid; Humans; Receptors, AMPA; Tissue Plasminogen Activator | 1997 |
Duration of glutamate release after acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Disorders; Disease Progression; Female; Glutamic Acid; Humans; Male; Middle Aged; Time Factors | 1997 |
Gene therapy for the nervous system.
Topics: Animals; Cell Death; Cerebrovascular Disorders; Dopamine; Genetic Therapy; Genetic Vectors; Glutamic Acid; Humans; Nervous System Diseases; Neurons; Neurotransmitter Agents; Parkinson Disease; Proto-Oncogene Proteins c-bcl-2; Viruses | 1997 |
Etiology of (CAG)n triplet repeat neurodegenerative diseases such as Huntington's disease is connected to stimulation of glutamate receptors.
Topics: Autoimmunity; Cerebrovascular Disorders; Epilepsy; Glutamic Acid; Humans; Huntington Disease; Minisatellite Repeats; Models, Biological; Nerve Degeneration; Receptors, Glutamate; Trinucleotide Repeats | 1997 |
Glutamate induced astroglial swelling--methods and mechanisms.
Topics: Animals; Astrocytes; Brain Injuries; Cell Size; Cells, Cultured; Cerebrovascular Disorders; Glutamic Acid; Rats | 1997 |
Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases.
Topics: Adult; Albumins; Central Nervous System Diseases; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Epilepsy; Female; Glutamic Acid; Humans; Hypoxanthine; L-Lactate Dehydrogenase; Lactic Acid; Male; Meningitis, Viral; Middle Aged; Multiple Sclerosis; Serum Albumin; Spinal Cord Diseases; Uric Acid; Xanthine | 1997 |
NO NMDA receptor activity.
Topics: Animals; Brain; Calcium Channel Blockers; Cerebrovascular Disorders; Electron Spin Resonance Spectroscopy; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Magnetic Resonance Imaging; Mice; Nitric Oxide; Radiography; Receptors, N-Methyl-D-Aspartate | 1996 |
A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
Topics: Albuminuria; Amino Acid Substitution; Angina Pectoris; Aspartic Acid; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Exons; Genotype; Glutamic Acid; Humans; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peripheral Vascular Diseases; Point Mutation; Risk Factors | 1998 |
Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Benzazepines; Cerebral Infarction; Cerebrovascular Disorders; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Haloperidol; Rats; Rats, Sprague-Dawley; Sulpiride; Urinary Bladder; Urinary Bladder, Neurogenic | 1999 |
Pathogenic mechanisms in ischemic damage: a computational study.
Topics: Acute Disease; Algorithms; Brain; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Cerebrovascular Disorders; Computer Simulation; Cortical Spreading Depression; Glutamic Acid; Humans; Models, Biological; Models, Chemical; Potassium; Tissue Survival | 1999 |
No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke.
Topics: Aged; Alleles; Aspartic Acid; Brain Ischemia; Cerebrovascular Disorders; Female; Genotype; Glutamic Acid; Humans; Male; Middle Aged; Nitric Oxide Synthase; Odds Ratio; Polymorphism, Genetic | 1999 |
Framing beta-amyloid.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Brain; Cerebrovascular Disorders; Codon; Genotype; Glutamates; Glutamic Acid; Glutamine; Humans; Molecular Sequence Data; Mutation; Phenotype; Protein Structure, Secondary | 1992 |
Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain: an in vivo microdialysis study.
Topics: Amino Acids; Animals; Animals, Newborn; Biological Transport, Active; Brain Ischemia; Cerebrovascular Disorders; Dialysis; Disease Models, Animal; Glutamates; Glutamic Acid; Hippocampus; Hypoxia, Brain; Rats; Rats, Inbred Strains | 1991 |
Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke.
Topics: Animals; Cerebrovascular Disorders; Dizocilpine Maleate; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Glutamic Acid; Intracranial Embolism and Thrombosis; Nervous System Diseases; Nimodipine; Rabbits; Tissue Plasminogen Activator | 1991 |
Adenosinergic approaches to stroke therapeutics.
Topics: Adenosine; Aspartic Acid; Cerebrovascular Disorders; Glutamates; Glutamic Acid; Humans; Receptors, Purinergic | 1990 |
NMDA receptors trigger excitement.
Topics: Aspartic Acid; Brain; Brain Ischemia; Cell Survival; Cerebrovascular Disorders; Electrophysiology; Glutamates; Glutamic Acid; Glycine; Heart Diseases; Humans; Ion Channels; Learning; Memory; Neurons; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Synapses | 1988 |
Release of glutamate and of free fatty acids in vasogenic brain edema.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Body Fluids; Brain Edema; Cats; Cerebrovascular Disorders; Extracellular Space; Fatty Acids, Nonesterified; Female; Glutamates; Glutamic Acid; Male; Osmolar Concentration | 1989 |